MTMeryem Temiz-Resitoglu

Meryem Temiz-Resitoglu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meryem Temiz-Resitoglu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Difluoromethoxy-Substituted Hexahydroquinolines as Multi-Target Anti-Inflammatory Agents: Mechanistic and Metabolomic Insights

    by Ezgi Pehlivanlar-Yavrucu, Ayca Aktas-Sukuroglu, Meryem Temiz-Resitoglu, Ozan Kaplan, Esra Ebraheem Al Jomaa, Taskin Kalkan, Seyhan Sahan-Firat, Rahime Simsek

    1. Inflammation is a complex biological response that plays a pivotal role in the pathogenesis of numerous human diseases. It is broadly classified into acute and chronic forms. Acute inflammation ...

  • Open Access

    mTOR inhibition modulates apoptosis and oxidative stress in hindlimb ischemia/reperfusion injury

    by Zarife Pi̇re, Demet Sinem Güden, Meryem Temi̇z Reşi̇toğlu, Sefika Pınar Şenol, Özden Vezi̇r, Nehir Sucu, Bahar Tunçtan, Kafait U. Mali̇k, Seyhan Şahan Firat

    Purpose: Ischemia/reperfusion (I/R)-induced injuries represent serious clinical events regarding profound target organ destructions followed by remote organ complications due to the loss of oxidant/antioxidant balance and apoptosis. Recent studies examining the mammalian target of rapamycin (mTOR) during I/R injury in different organs have remained a matter of debate. The current study aimed to explore further the protective and underlying antiapoptotic and antioxidant mechanisms of mammalian target of rapamycin (mTOR) inhibition in hindlimb (HL) schemia/reperfusion (I/R)injury. Materials and Methods: Occlusion of bilateral hindlimbs for 4 h with tourniquets was carried out under anesthesia to induce I/R for 4 h in rats. Rapamycin (1 mg/kg) or saline (4 mL/kg) was injected intraperitoneally 1 h before reperfusion. Gastrocnemius muscle, kidney, and blood were collected at the end of the experiments for analysis. Muscle and kidney damages were evaluated by measuring protein expression and/or phosphorylation of eukaryotic initiation factor 4E-binding protein 1 (4EBP1), ribosomal protein S6 (rpS6), B-cell lymphoma 2 (Bcl-2), caspase-3, and Bcl-2-associated X protein (Bax) with NADPH oxidase level and total antioxidant capacity in tissues or sera. Results: I/R-induced organ damages were demonstrated by enhanced phosphorylation and/or expression of rpS6, 4EBP1, caspase-3, and Bax with a significant reduction in Bcl-2 accompanied by a decreased total antioxidant capacity and increased level of NADPH oxidase. Administration of rapamycin, an inhibitor mTOR, protected against I/R-mediated injuries. Conclusion: Our findings suggest that the activation of mTOR signaling plays a crucial role in HL I/R-triggered organ damages presumably through the activation of apoptosis as a result of oxidant/antioxidant imbalance.


  • Open Access

    Inhibition of mTOR protects against skeletal muscle and kidney injury following hindlimb ischemia-reperfusion in rats by regulating MEK1/ERK1/2 activity

    by Çağla Akinci Uysal, Meryem Temi̇z Reşi̇tOğlu, Demet Sinem Güden, Sefika Pınar Şenol, Özden Vezi̇r, Nehir Sucu, Bahar Tunçtan, Kafait U. Mali̇k, Seyhan Firat

    Purpose: We have previously demonstrated that activation of the mammalian target of rapamycin (mTOR)/inhibitory-κB-α/nuclear factor-κB p65 signaling pathway mediates organ injuries through increased oxidative/nitrosative stress and inflammatory response in rat models of hind limb ischemia/reperfusion (HL I/R). Following up our previous findings regarding I/R injury through mammalian target of rapamycin (mTOR), we aimed to focus on the possible interaction between mammalian target of rapamycin (mTOR and mitogen-activated protein kinase kinase (MEK)1/extracellular signal-regulated kinase (ERK) 1/2 pathway in hind limb ischemia/reperfusion (HL I/R) resulting in target and remote organ injuries in the present study. Materials and Methods: Male Wistar rats were divided into four groups. HL I/R was induced by occluding with tourniquets of both hind limbs. Following 4 h, the tourniquets were removed following reperfusion for 4 h. After 4 h of reperfusion blood, kidney, and gastrocnemius muscle were collected. Results: HL I/R caused an increase in phosphorylation and/or expression of rpS6, MEK1, ERK1/2, tumor necrosis factor-α, inducible nitric oxide synthase, gp91phox, p22phox, and nitrotyrosine as well as nitrite levels in gastrocnemius muscle, kidney, and/or serum. Additionally, nicotinamide adenine dinucleotide phosphate oxidase and myeloperoxidase levels were increased in the tissues of rats subjected to HL I/R. Rapamycin, the selective inhibitor of mTOR, abolished all the effects mentioned above caused by HL I/R in the rat’s muscle and kidney. Conclusion: These data suggest that activation of the MEK1/ERK1/2 pathway contributes to mTOR-mediated HL I/R-induced target and remote organ injury.


  • Open Access

    Polyphenols and targets in age-related disorders; mTOR signalling pathway

    by Seyhan Şahan Firat, Meryem Temi̇z Resi̇toglu

    Dünya çapında, yaşa bağlı hastalıkların insidansının artmasıyla birlikte mortalite ve morbiditenin de yüksek olması yaşlanmayı yavaşlatan veya geciktiren müdahalelerin geliştirilmesine neden olmaktadır. Son yıllarda yaşa bağlı gelişebilecek bozukluklarla ilgili yapılan araştırmalar mTOR sinyal ileti yolu üzerinde yoğunlaşmıştır. mTOR ve yapısına dahil olduğu kompleksler yaşlanma ile ilişkilendirilen en önemli hücresel sinyal ileti yolu molekülleri olarak kabul edilmektedir. Ayrıca, mTOR inhibitörleri ile ilgili yaşlanma sürecini yavaşlatabildiklerine dair bulguların ortaya çıkması bu konu üzerindeki ilgiyi giderek arttırmaktadır. Bu derlemede, yaşa bağlı gelişebilecek bozukluklarda mTOR sinyal ileti yolunu hedefleyen diyet türevi doğal polifenolik bileşiklerle ilgili güncel bilgiler derlenmiştir. Ayrıca, polifenollerin yaşa bağlı bozukluklarının moleküler patojenezi üzerindeki etkilerinden de bahsedilmiştir.

  • Targeting mTOR: up-to-date mTOR inhibitors

    by Banu Kilic, Meryem Temiz-Resitoglu, Seyhan Sahan Firat

    MTOR, a member of the phosphatidylinositol 3-kinase-related kinase family, controls major physiological cellular processes such as growth and metabolism in response to nutrients, growth factors, and cellular energy levels. Furthermore, deregulation of the mTOR activity has been associated with various pathological conditions such as cancer, diabetes, obesity, neurological diseases, and genetic disorders. Therefore, research on the mTOR signalling pathway and the development of effective molecules on this pathway has been continuing intensively in recent years. In the past decade, numerous mTOR inhibitors have been developed and many are currently in clinical trials. These molecules are classified as Rapamycin and its analogs (all are termed rapalogs), ATP-competitive dual PI3K/mTOR inhibitors, mTOR kinase inhibitors, and Rapa Links. In this review, we aimed to summarize current findings on mTOR signalling network and molecules acting on this signalling pathway.